Mesenchymal stem cells prevent the progression of diabetic nephropathy by improving mitochondrial function in tubular epithelial cells

The administration of mesenchymal stem cells (MSCs) was shown to attenuate overt as well as early diabetic nephropathy in rodents, but the underlying mechanism of this beneficial effect is largely unknown. Inflammation and mitochondrial dysfunction are major pathogenic factors in diabetic nephropath...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seung Eun, Jang, Jung Eun, Kim, Hyun Sik, Jung, Min Kyo, Ko, Myoung Seok, Kim, Mi-Ok, Park, Hye Sun, Oh, Wonil, Choi, Soo Jin, Jin, Hye Jin, Kim, Sang-Yeob, Kim, Yun Jae, Kim, Seong Who, Kim, Min Kyung, Sung, Chang Ohk, Pack, Chan-Gi, Lee, Ki-Up, Koh, Eun Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802630/
https://www.ncbi.nlm.nih.gov/pubmed/31285429
http://dx.doi.org/10.1038/s12276-019-0268-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802630/
https://www.ncbi.nlm.nih.gov/pubmed/31285429
http://dx.doi.org/10.1038/s12276-019-0268-5

Ejemplares similares